Target intelligence / Profile preview

Ribosomal protein L11 pseudogene 1 (RPL11P1)

Target: RPL11P1
Molecular classification: Other (processed pseudogene)

Overview

Ribosomal protein L11 pseudogene 1 (RPL11P1) is a processed pseudogene; it arose via reverse transcription and genomic integration of RPL11 mRNA[4][6]. Processed pseudogenes such as RPL11P1 resemble their parent genes in sequence but are nonfunctional due to accumulated mutations, truncations, and lack of regulatory elements[4][6]. RPL11P1 does not contribute to ribosome structure or function, is not involved in disease or therapeutic processes, and does not interact with drugs. Its existence is noted primarily for genomic studies and does not extend to biology or medicine in the context of a molecular target.

Other names: RPL11_1_236RPL11P1

Beyond the preview

Go deeper on Ribosomal protein L11 pseudogene 1 (RPL11P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L11 pseudogene 1 (RPL11P1).

Explore the full profile